Baptist University Led News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hong Kong unveils next-gen drug for cancers associated with Epstein–Barr virus
Hong Kong unveils next-gen drug for cancers associated with Epstein–Barr virus
03 March 2021 | News
HKBU has established a spin-off company named BP InnoMed Limited (BPI) to further develop this new anti-EBV drug and carry out clinical trials
Source: PR Newswire
A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the potential to become a next-generation treatment for cancers associated with Epstein–Barr virus (EBV).
The peptide-linked drug, which is responsive to the acidic environment found in tumours, is the first known agent to have successfully targeted two viral proteins that are simultaneously produced by EBV.  ....

Hong Kong , Hong Lok , A Hong Kong , Gary Wong Ka Leung , Department Of Chemistry , Department Of Applied Biology , Hong Kong Polytechnic University , Sun Yat Sen University , Chemical Technology , Bp Innomed Limited , Baptist University Led , Assistant Professor , Law Ga Lai , Associate Professor , Applied Biology , Med Limited , Third Affiliated Hospital , Sun Yat Sen , Hong Kong Baptist University , Epstein Barr Virus , Professor Gary Wong Ka Leung , Cancer Drug , Tumour Cell , ஹாங் காங் , ஹாங் லோக் , ஹாங் காங் ,